SHMN.US Sohm Inc.

Healthcare Pharmaceuticals USA Stocks
0.0006 USD
Close of Nov 14, 2026
0.0006 0.0015
Market cap
USD 1.74M
P/E
-
P/B
-
ROE
-21.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is SHMN.US undervalued?

Graham number

The Graham number of Sohm Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sohm Inc. fundamental analysis

No fundamental analysis for Sohm Inc. yet.

Sohm Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sohm Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and g…

Full company profile